Can Zonisamide Cause Bradycardia?
Yes, zonisamide can cause bradycardia, though this is a rare but documented adverse effect that occurred in at least one severe overdose case requiring hospitalization.
Evidence from FDA Drug Labeling
The FDA prescribing information for zonisamide explicitly documents bradycardia as a cardiovascular manifestation in overdose situations. In one documented case, a patient who ingested an unknown amount of zonisamide as a suicide attempt developed bradycardia along with hypotension and respiratory depression 1. This patient became comatose with a zonisamide plasma level of 100.1 mcg/mL measured 31 hours post-ingestion, and required five days to become alert 1.
Absence in Standard Adverse Event Profiles
Importantly, bradycardia is not listed among the common or even uncommon adverse events in therapeutic dosing scenarios. The FDA labeling identifies the most common adverse events as fatigue, dizziness, somnolence, anorexia, and abnormal thinking 1. The comprehensive guideline review from the American Academy of Neurology and American Epilepsy Society similarly does not mention bradycardia among adverse events in clinical trials 2.
The pediatric safety analysis of 398 patients (mean exposure 318.7 days) reported no cardiovascular adverse events or clinically significant ECG abnormalities with zonisamide treatment 3.
Clinical Context and Mechanism
The FDA labeling notes that zonisamide can cause "changes in heartbeat" as a potential manifestation of metabolic acidosis 1. However, the specific bradycardic effect appears to be:
- Dose-dependent: Only documented in severe overdose
- Part of systemic toxicity: Occurred alongside CNS depression, hypotension, and respiratory compromise
- Not a therapeutic-dose concern: Absent from controlled trials and large safety databases
Practical Recommendations
Monitor for bradycardia only in overdose situations or when zonisamide is combined with other medications known to cause bradycardia. In therapeutic dosing:
- Routine cardiac monitoring is not indicated based on available evidence
- Focus monitoring on the well-established adverse effects: metabolic acidosis (check bicarbonate levels), kidney stones, decreased sweating/hyperthermia, and cognitive effects 1
- If bradycardia develops during therapeutic use, investigate other causes first (drug interactions, underlying cardiac disease, electrolyte abnormalities)
In overdose scenarios, expect potential bradycardia as part of the toxidrome and prepare for supportive care including possible vasopressor support, as demonstrated in the documented case 1.